Published in Medicine (Baltimore) on September 01, 2016
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol (2005) 18.76
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 9.54
Hospital-acquired renal insufficiency. Am J Kidney Dis (2002) 7.90
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29
The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med (1977) 4.13
The economic impact of acute kidney injury in England. Nephrol Dial Transplant (2014) 2.40
Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem (1997) 1.92
Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med (1974) 1.80
Effect of hypophosphatemia on myocardial performance in man. N Engl J Med (1977) 1.70
Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm (2013) 1.54
Danger signals activating the immune response after trauma. Mediators Inflamm (2012) 1.40
Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract (2013) 1.32
Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci (2006) 1.23
Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis (2011) 1.17
Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant (2011) 1.14
Medication-induced hypophosphatemia: a review. QJM (2010) 1.12
Serum phosphate abnormalities in the emergency department. J Emerg Med (2002) 1.02
Continuous renal replacement therapy in sepsis and multisystem organ failure. Semin Dial (2009) 0.99
Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study. PLoS One (2013) 0.99
Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant (2011) 0.99
Hyponatremia in the emergency department. Am J Emerg Med (2000) 0.96
Hypophosphatemia in postoperative patients with total parenteral nutrition: influence of nutritional support teams. Nutr Hosp (2006) 0.95
Severe unexplained hypophosphatemia. Clin Chem (1992) 0.94
Persistently elevated osteopontin serum levels predict mortality in critically ill patients. Crit Care (2015) 0.92
Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol (2008) 0.91
Revisiting caspases in sepsis. Cell Death Dis (2014) 0.91
Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol (2007) 0.88
The relationship between serum potassium, potassium variability and in-hospital mortality in critically ill patients and a before-after analysis on the impact of computer-assisted potassium control. Crit Care (2015) 0.87
Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury. Int Urol Nephrol (2012) 0.86
Hypophosphatemia in critically ill patients. J Crit Care (2012) 0.86
Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock. Chest (1995) 0.86
Sepsis-induced acute kidney injury. Indian J Crit Care Med (2010) 0.86
Acid-base and electrolyte abnormalities during renal support for acute kidney injury: recognition and management. Blood Purif (2012) 0.85
Yin and Yang: acute kidney injury and chronic kidney disease. J Am Soc Nephrol (2008) 0.83
Acute kidney injury in intensive care unit: incidence, risk factors and mortality rate. Saudi J Kidney Dis Transpl (2011) 0.83
High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial. Am J Kidney Dis (2016) 0.83
Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care (2013) 0.80
Effect of phosphate depletion on blood pressure and vascular reactivity to norepinephrine and angiotensin II in the rat. Am J Physiol (1985) 0.80
Hypomagnesemia and cardiovascular system. Hippokratia (2006) 0.78
Update of acute kidney injury: intensive care nephrology. Hippokratia (2011) 0.78
The incidence of electrolyte and acid-base abnormalities in critically ill patients using point of care testing (i-STAT portable analyser). Nig Q J Hosp Med (2012) 0.77
Acute Kidney Injury Recognition and Management: A Review of the Literature and Current Evidence. Glob J Health Sci (2015) 0.77
Effects of Hyponatremia on the Brain. J Clin Med (2014) 0.77
Hypophosphatemia on the intensive care unit: individualized phosphate replacement based on serum levels and distribution volume. J Crit Care (2013) 0.77
Phosphorus as an early marker of morbidity and mortality in type 2 chronic kidney disease diabetic patients. J Diabetes Complications (2013) 0.76
A fluid and electrolyte balance service for clinical use. J Am Med Assoc (1952) 0.76
Magnesium Toxicity-Induced Ileus in a Postpartum Patient Treated for Preeclampsia With Magnesium Sulphate. ACG Case Rep J (2015) 0.76
Reversible depression of myocardial performance in hypophosphatemia. Am J Med Sci (1988) 0.76
Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int (2004) 2.13
Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int (2007) 1.83
Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis (2013) 1.76
Transport infrastructure surveillance and monitoring by electromagnetic sensing: the ISTIMES project. Sensors (Basel) (2010) 1.60
Risk factors for adverse outcomes after peritonitis-related technique failure. Perit Dial Int (2008) 1.54
Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant (2009) 1.53
Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients. Nephrol Dial Transplant (2009) 1.50
Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behçet's disease. J Invest Dermatol (2011) 1.46
Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. Nephrol Dial Transplant (2010) 1.46
Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One (2013) 1.37
Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy. Nephrol Dial Transplant (2011) 1.34
The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int (2008) 1.34
Red blood cell distribution width is an independent predictor of mortality in patients with gram-negative bacteremia. Shock (2012) 1.34
Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report. Am J Kidney Dis (2010) 1.31
Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol (2012) 1.21
Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant (2007) 1.19
Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis (2011) 1.16
An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care (2013) 1.14
Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant (2009) 1.11
Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem (2012) 1.09
Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol (2004) 1.08
Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One (2012) 1.08
Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol (2002) 1.07
Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS One (2013) 1.06
Long-term clinical outcomes of peritoneal dialysis patients: single center experience from Korea. Perit Dial Int (2008) 1.05
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC Nephrol (2014) 1.04
Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab (2012) 1.04
Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metabolism (2010) 1.03
Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol Dial Transplant (2010) 1.03
Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid (2013) 1.03
Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res Clin Pract (2011) 1.03
Differential expression of nephrin according to glomerular size in early diabetic kidney disease. J Am Soc Nephrol (2007) 1.02
Clinical implications of subclinical hypothyroidism in continuous ambulatory peritoneal dialysis patients. Am J Nephrol (2008) 1.02
Clinical implication of crescentic lesions in immunoglobulin A nephropathy. Nephrol Dial Transplant (2013) 1.02
Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol (2012) 1.01
Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int (2009) 1.00
Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center. Perit Dial Int (2010) 0.99
Mortality of IgA nephropathy patients: a single center experience over 30 years. PLoS One (2012) 0.99
Visceral fat thickness is associated with carotid atherosclerosis in peritoneal dialysis patients. Obesity (Silver Spring) (2011) 0.98